Charles River Labs Intl buy The Goldman Sachs Group, Inc.
Start price
23.01.25
/
50%
€159.40
Target price
23.01.26
€182.70
Performance (%)
16.56%
End price
24.01.26
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 16.56%. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | -1.901% | -1.901% | 16.016% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $220.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€199.65
06.06.24
06.06.24
€266.42
06.06.25
06.06.25
-36.41%
07.06.25
07.06.25
